First vaccine approval under the FDA Animal Rule
- PMID: 29263855
- PMCID: PMC5707879
- DOI: 10.1038/npjvaccines.2016.13
First vaccine approval under the FDA Animal Rule
Abstract
The US Food and Drug Administration's Animal Rule was established to facilitate licensure of new products for life-threatening conditions when traditional efficacy trials in humans are unethical or impractical. In November, 2015 BioThrax became the first vaccine to receive approval for a new indication via this pathway. The basis for this approval and use of Animal Rule or other non-traditional approval pathways for licensure of vaccines for serious conditions are discussed.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- FDA. FDA approves vaccine for use after known or suspected anthrax exposure, Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm474027.htm (2015).
-
- FDA. November 23, 2015, Approval Letter—Biothrax, Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedPro... (2015).
-
- Russek-Cohen, E. et al. A US Food and Drug Administration perspective on evaluating medical products for Ebola. Clin. Trials 13, 105 (2016). - PubMed
-
- Krause, P. R., Cavaleri, M., Coleman, G. & Gruber, M. F. Approaches to demonstration of Ebola virus vaccine efficacy. Lancet Infect. Dis. 15, 627 (2015). - PubMed
-
- Health_Canada. Guidance Document—Submission and Information Requirements fo Extraordinary Use New Drugs (EUNDs), Available at: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/brgtherap/applic-demande/... (2014).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources